1Hauschiild S, Schmitt WH,Csermok E, et al. ANCA in wegener, s granulomatosis and related vasculitides[J]. Adv Exp Med Biol, 1992,49(8) :875-876.
2Zhao MH, Jones SJ, Lockwood CM. Bactericidal/permeability-in- creasing protein (BPI) is an important antigen for anti-neutrophil cytoplasmic autoantibodies (ANCA) in vasculitis[J]. Clin Exp Immunol, 1995,99(1) :49-56.
3By E, Christiaan H, Bart E, et al. Antineutrophil cytoplasmic anti boclies :a review of the antigens involved, the assays, and the clinal and possible pathogenetic conseqnences[J]. Blood, 1993,81 (8) : 1996-2002.
4Oudkerk PM, Ellerbroek PM, Ridwan BU, et al. Serum antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease are mainlyassociated with ulcerative colitis[J]. Gut, 1993,34 ( 1 ) : 46-50.
5Specks V,Wheatley CL. Antieytoplasmic antoantibobies in the di- agnosis and follow-up of Wegener's granulomatosis[J]. Mayo Clin Proc,1989,64(5) :28-36.
6Hagen EC. Development and standardization of solid-phase assays for the detection of antineutrophil cytoplasmic antibodies (AN- CA) for clinical application: report of a large clinical evaluation study[J]. Clin Exp Immunol,1995,101(Suppl ) :29.
7Jayne DR, Davies M J, Fox CJ, et al. Treatment of systemic vascul- itis with pooled intravenous immunoglobulin[J]. Lancet,1991,337 (8750) : 1137-1139.
8Rao JK,Allen NB,Feussner JR,et al. A prospective study of anti- neutrophil cytoplasmic antibody (c-ANCA) and clinical criteria in diagnosing Wegener' s granulomatosis[ J ]. Lancet, 1995, 346 (8980) :926 -931.
9Guillevin L,Visser H, Noel LH, et al. Antineutrophil cytoplasmic antibody in systemic polyarteritis nodosa with and without hepati- tis B virus infection and C hurg Strass syndromes62 patients[J]. J Rheumatol, 1993,20 (5): 1345-1349.
10Ronda N, Esnault VL, Layward L, et al. Antineutrophil cytoplasm antibodies (ANCA) of IgA isotype in adult Henoch-Schinlein purpura[J]. Clin Exp Immunol,1994,95(1) :49-55.
